Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Total Liabilities (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Total Liabilities for 2 consecutive years, with $38.1 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 4.62% to $38.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $38.1 million through Dec 2025, up 4.62% year-over-year, with the annual reading at $38.1 million for FY2025, 4.62% up from the prior year.
  • Total Liabilities for Q4 2025 was $38.1 million at Pyxis Oncology, up from $36.8 million in the prior quarter.
  • The five-year high for Total Liabilities was $41.6 million in Q3 2024, with the low at $32.8 million in Q1 2025.